Results
1 -
10 of
17
(Click
here to explore results)
- Neglected Diseases and Drug Discovery, Chapter 10 Diarrhoeal Diseases. David Brown,
, 2012
, Pages 262-289
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 10 Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses. B. Mercorelli, A. Loregian
, 2022
, Pages 232-255
- Neglected Diseases and Drug Discovery, Chapter 11 Anthelmintic Discovery for Human Infections. Timothy G. Geary, Noelle Gauvry
, 2012
, Pages 290-321
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 15 COVID-19 Pharmacotherapy – Present and Future. Deepak Kumar, Ravi Mangalia, Mahadev Meena, Varatharajan Sakthivadivel, Gopal Krishna Bohra, Stafford Warren
, 2022
, Volume 1
, Pages 412-454
- Antibiotic Drug Discovery: New Targets and Molecular Entities, CHAPTER 1 Treatment of Clostridium difficile Infections. Christopher Yip, Jacqueline Phan, Ernesto Abel-Santos
, 2017
, Pages 1-19
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, Contents
, 2022
, Volume 2
, Pages P019-P030
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, Contents
, 2022
, Volume 1
, Pages P019-P030
- Antibiotic Drug Discovery: New Targets and Molecular Entities, Subject Index
, 2017
, Pages 256-271
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Subject Index
, 2022
, Pages 280-290
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27